ArticleThe American journal of case reports2025
Low Antigen Titre Disseminated Cryptococcosis in Immunocompromised Hosts: Two Challenging Case Reports.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Cryptococcus is a yeast-like fungus commonly found in soil and typically causes disease in immunocompromised individuals due to impaired cell-mediated immunity. While the central nervous system (CNS) and lungs are most frequently affected, disseminated disease can involve multiple organs, including the skin, liver, spleen, kidneys, and bone marrow. Symptoms such as headache, fever, and altered mental status often require extensive diagnostic evaluation. CASE REPORT We present 2 unusual cases of cryptococcal growth in the blood without meningoencephalitis, with low cryptococcal antigen titres (1: 80 in both cases). The first case involves a post-kidney transplant patient with respiratory symptoms who underwent bronchoalveolar lavage (BAL), revealing Cryptococcus growth. A subsequent positive blood culture confirmed disseminated cryptococcosis, and the patient was treated with antifungal therapy. The second case is of a patient with HIV, non-adherent to treatment, who developed a complicated infection course. The cryptococcal antigen was positive in the serum, prompting treatment with a high-dose antifungal regimen. Despite negative results in BAL and cerebrospinal fluid, the blood culture was positive for Cryptococcus, necessitating intensive antifungal therapy according to protocolized guidelines. CONCLUSIONS These cases highlight the unusual presentation of disseminated cryptococcal infection with low serum antigen titres (1: 80) and positive blood culture, indicating disseminated infection even without CNS involvement. This emphasizes the importance of considering disseminated cryptococcosis in the differential diagnosis of immunocompromised patients, even with low antigen titres in serum. It suggests that clinicians should order blood cultures to alter management strategies, particularly in patients with atypical presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.